Sapio HealthSapio Health
  • Today
  • Patients
  • Inbox
  • Calendar
Insight
  • Population
  • Quality (QOF)
System
  • Models
  • Data feeds
  • Settings
Practice trajectory
-26%
JD
Dr John Dolittle
Ashford Vale Medical Group
Patients/Oliver Bennett · SH-10389
← Practice Horizon

Oliver Bennett

72M · SH-10389APP
AF + CKD stage 3 · Retired (accountant)
Next consult
Fri 17 Apr, 15:45
Positive· p 0.72Steady
Trajectory headline
Rate controlled, anticoagulated, CKD stable. Review focuses on adherence and fall-risk / bleeding balance.
Model priority
Positive zone
Biggest single change you could makeAdd SGLT2 → −14% (eGFR)
Patient Context Card · AIME

Brief

Trajectory-grounded orientation for today's appointment.

AF + CKD stable. Today is maintenance — adherence, bleeding, renal function.

Trajectory narrative

Oliver has permanent AF on apixaban and bisoprolol, CKD stage 3b (eGFR hovering 42–46). No bleeding events. Wearable HR suggests occasional rate excursions during activity — worth a conversation but not a red flag. The plan is unchanged: maintain, watch eGFR.

Active concerns
  • eGFR 44 (from 48 a year ago — mild drift)
  • HAS-BLED 2; CHA₂DS₂-VASc 4
  • Rate occasionally exceeds 110 on exertion
Suggested consultation focus
  • Check U&E + eGFR; adjust apixaban if needed
  • Reinforce fall-prevention (shoes, home hazards)
  • Discuss wearable HR pattern
Supporting record context
Current medications
Apixaban 5mg BD · Bisoprolol 5mg · Amlodipine 5mg · Atorvastatin 20mg
Allergies
NKDA
For demonstration purposes. Not a diagnostic tool.
Horizon-1 · Syndrome activation

Latent clinical states

Output of the dynamic hypergraph. Direction = trajectory on that axis.

Atrial fibrillation
0.68
CKD stage 3
0.54
For demonstration purposes. Not a diagnostic tool.